stockrow
Monday 9 November 2026
Export DRUG’s income statement to Excel — free account
Bright Minds Biosciences Inc.
DRUG- EPS
- +67.9%
- Free cash flow
- −124.6%
- Total debt
- −84.7%
Quarter to June 2026, against a year earlier
23.00
2.30
+11.11%
Follow DRUG
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (13.64%) | (15.00%) | (26.97%) | (27.88%) |
+8 more TTM periods Free account |
|
| (13.52%) | (14.81%) | (26.58%) | (26.97%) | ||
ROIC |
0.00% | 0.00% | (4,805.72%) | 0.00% | |
Return on Tangible Assets |
(7.97%) | (8.79%) | (22.20%) | (14.92%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.81) | (1.51) | (1.20) | (0.90) | |
Free Cash Flow |
(17.75) | (14.46) | (9.32) | (6.21) | |
| Other line items | |||||
Cash ROIC |
(3.99%) | (3.21%) | (7.28%) | (5.27%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.00 | 0.73 | 0.66 | 0.71 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.81) | (1.51) | (1.20) | (0.90) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026